Page last updated: 2024-10-22

amsacrine and Cardiac Failure

amsacrine has been researched along with Cardiac Failure in 2 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Research Excerpts

ExcerptRelevanceReference
"Seven patients developed clinical congestive heart failure."1.26Cardiac abnormalities after AMSA administration. ( Mangiacasale, D; Miller, DR; Steinherz, LJ; Steinherz, PG; Tan, C, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steinherz, LJ1
Steinherz, PG1
Mangiacasale, D1
Tan, C1
Miller, DR1
Thomas, X1
Fiere, D1
Archimbaud, E1

Other Studies

2 other studies available for amsacrine and Cardiac Failure

ArticleYear
Cardiac abnormalities after AMSA administration.
    Cancer treatment reports, 1982, Volume: 66, Issue:3

    Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Ch

1982
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia.
    Leukemia, 1998, Volume: 12, Issue:9

    Topics: Adult; Aged; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols;

1998